TIANJIN CHASE SUN PHARMACEUTICAL CO.,LTD

Tianjin Chase Sun Pharmaceutical Co.,Ltd

300026

CNE100000GF1

Pharmaceuticals

End-of-day quote Shenzhen S.E. Other stock markets 06:00:00 2024-04-29 pm EDT			5-day change	1st Jan Change
3.86 ^CNY	+1.58%		+4.61%	-8.96%

Mar. 01	Tianjin Chase Sun Pharmaceutical's 2023 Profit Slides 15% on Weak Revenue	MT
Feb. 29	Tianjin Chase Sun Pharmaceutical Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Tianjin Chase Sun Pharmaceutical Co.,Ltd Announces Profit Distribution Proposal for 2020

March 31, 2021 at 03:40 pm EDT

Tianjin Chase Sun Pharmaceutical Co.,Ltd announced profit distribution proposal of CNY 0.40000000 per 10 shares (tax included) for 2020.

Latest news about Tianjin Chase Sun Pharmaceutical Co.,Ltd

Tianjin Chase Sun Pharmaceutical's 2023 Profit Slides 15% on Weak Revenue	Feb. 29	MT
Tianjin Chase Sun Pharmaceutical Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 29	CI
Tianjin Chase Sun Pharmaceutical Co.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-25	CI
Tianjin Chase Sun Pharma’s Muscle Relaxant Passes Drug Consistency Test	23-09-22	MT
Tianjin Chase Sun Pharmaceutical Co.,Ltd Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-29	CI
Tianjin Chase Sun Pharmaceutical Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-27	CI
Tianjin Chase Sun Pharmaceutical Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2022	23-02-27	CI
Tianjin Chase Sun Pharmaceutical Co.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-24	CI
Tianjin Chase Sun Pharmaceutical Co.,Ltd Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-29	CI
Tianjin Chase Sun Pharmaceutical Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2022	22-04-28	CI
Tianjin Chase Sun Pharmaceutical Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2021	22-02-27	CI
Tianjin Chase Sun Pharmaceutical Co.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2021	21-10-28	CI
Tianjin Chase Sun Pharmaceutical Co.,Ltd Reports Earnings Results for the Half Year Ended June 30, 2021	21-08-27	CI
Tianjin Chase Sun Pharmaceutical Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2021	21-04-27	CI
Tianjin Chase Sun Pharmaceutical Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2020	21-03-30	CI
Tianjin Chase Sun Pharmaceutical Co.,Ltd cancelled the acquisition of additional 25% stake in Hubei Enoray Biopharmaceutical Co., Ltd. from Hubei Wurui Biotechnology Co., Ltd. for CNY 60 million.	21-01-18	CI
Tianjin Chase Sun Pharmaceutical Co.,Ltd Announces the Election of Li Li as an Independent Director	20-11-19	CI
Tianjin Chase Sun Pharmaceutical Co.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2020	20-10-29	CI
Tianjin Chase Sun Pharmaceutical Co.,Ltd(XSEC:300026) added to S&P Global BMI Index	20-09-21	CI
Tianjin Chase Sun Pharmaceutical Co.,Ltd Reports Earnings Results for the Half Year Ended June 30, 2020	20-08-24	CI
Starpharma Announce Signs New Research Partnership with Tianjin Chase Sun Pharmaceutical Co., Ltd	20-08-16	CI
Tianjin Chase Sun Pharmaceutical Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2020	20-04-28	CI
Tianjin Chase Sun Pharmaceutical Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2019	20-04-27	CI
Tianjin Chase Sun Pharmaceutical Co.,Ltd intends to acquire additional 25% stake in Hubei Enoray Biopharmaceutical Co., Ltd. from Hubei Wurui Biotechnology Co., Ltd. for CNY 60 million.	20-01-21	CI
Tianjin Chase Sun Pharmaceutical Co.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2019	19-10-28	CI

Chart Tianjin Chase Sun Pharmaceutical Co.,Ltd

Duration

Period

Chart Tianjin Chase Sun Pharmaceutical Co.,Ltd

More charts

Tianjin Chase Sun Pharmaceutical Co.,Ltd is a China-based company principally engaged in the research, development, manufacture and distribution of pharmaceuticals. The Company's main products include Chinese traditional formula granules, Xuebijing injection, fasudil hydrochloride injection, low molecular weight heparin calcium injection, bulk drugs and excipient, among others. The Company also provides medical apparatus and instrument. The Company distributes its products in domestic market and to overseas markets.

Sector

Pharmaceuticals

Calendar

2024-08-26 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for Tianjin Chase Sun Pharmaceutical Co.,Ltd

Trading Rating

Investor Rating

ESG Refinitiv

C-

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

3.86 CNY

Average target price

4 CNY

Spread / Average Target

+3.63%

Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Alternative Medicine

	1st Jan change	Capi.
TIANJIN CHASE SUN PHARMACEUTICAL CO.,LTD	-8.96%	1.6B
DONG-E-E-JIAO CO.,LTD.	+39.33%	6.11B
SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.	-18.38%	4.35B
TASLY PHARMACEUTICAL GROUP CO., LTD	-9.17%	3.19B
TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED	+3.98%	3.15B
SHANDONG BUCHANG PHARMACEUTICALS CO., LTD.	-3.41%	2.51B
HENAN LINGRUI PHARMACEUTICAL CO., LTD.	+48.74%	1.98B
GUANGYUYUAN CHINESE HERBAL MEDICINE CO., LTD.	-4.82%	1.74B
TIBET CHEEZHENG TIBETAN MEDICINE CO., LTD.	-1.24%	1.63B
ZHEJIANG JOLLY PHARMACEUTICAL CO.,LTD	+39.87%	1.45B

Alternative Medicine